Green Cross Holdings
KRX:005250

Watchlist Manager
Green Cross Holdings Logo
Green Cross Holdings
KRX:005250
Watchlist
Price: 16 000 KRW 0.44% Market Closed
Market Cap: 765.9B KRW

Net Margin
Green Cross Holdings

5.2%
Current
0.1%
Average
-6.6%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
5.2%
=
Net Income
118.3B
/
Revenue
2.3T

Net Margin Across Competitors

No Stocks Found

Green Cross Holdings
Glance View

Market Cap
726.4B KRW
Industry
Biotechnology

Green Cross Holdings Corp. is a holding company of Green Cross Corp. that engages in the manufacture of pharmaceutical products. The company is headquartered in Yongin, Gyeonggi-Do. The Company’s products portfolio consists of prescription drugs, blood derivatives, vaccines, cerebrovascular disease treatment, hunter syndrome drugs, as well as over the counter (OTC) drugs, such as skin disease treatment drugs, allergic cream and others. Its products are used for analgesic, treatment of cerebral thrombosis, hypoalbuminemia, genodermatosis and others, as well as prevention of influenza, prophylaxis of varicella, among others. The firm is also involved in the real estate sales and leasing, as well as construction business.

Intrinsic Value
46 733.54 KRW
Undervaluation 66%
Intrinsic Value
Price
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
5.2%
=
Net Income
118.3B
/
Revenue
2.3T
What is the Net Margin of Green Cross Holdings?

Based on Green Cross Holdings's most recent financial statements, the company has Net Margin of 5.2%.

Back to Top